Indication

Malignant mesothelioma of pleura

Malignant mesothelioma of the pleura is an aggressive, rare cancer arising from the mesothelial cell lining of the chest wall and lungs. Read more about Malignant mesothelioma of pleura

27 drugs 24 manufacturers

Advertisement

Drugs that treat it

Common Malignant mesothelioma of pleura therapies.

Showing 10–18 of 27 drugs

PEMETREXED

FOLATE ANTAGONISTS·MALIGNANT MESOTHELIOMA OF PLEURA·+2
TEVA USA
Filter & compare in the drug finder →Opens the drug finder with Malignant mesothelioma of pleura preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Malignant mesothelioma of pleura.

Malignant mesothelioma of the pleura is an aggressive, rare cancer arising from the mesothelial cell lining of the chest wall and lungs.

It most commonly affects older adults with a history of occupational or environmental asbestos exposure, typically emerging after a latency period of several decades.

Pathophysiologically, inhaled fibers cause chronic inflammation, genetic damage, and diffuse tumor growth that encases the lung and invades adjacent thoracic structures.

Clinically, it is classified into epithelioid, sarcomatoid, or biphasic histologic subtypes and typically manifests with dyspnea, persistent nonpleuritic chest pain, and recurrent pleural effusions.

Personalize your experience

Follow Malignant mesothelioma of pleura and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it